According to BIOLIFE4D, “We have developed a proprietary bioink using a very specific composition of different extracellular matrix compounds that closely replicate the properties of the mammalian heart. Further, it has developed a novel and unique bioprinting algorithm, consisting of printing parameters optimized for the whole heart. Coupling its proprietary bioink with patient-derived cardiomyocytes and its enabling bioprinting technology, BIOLIFE4D is able to bioprint a heart that, while smaller in size, replicates many of the features of a human heart. With this platform technology in place, BIOLIFE4D is now well-positioned to build upon this platform and work towards the development of a full-scale human heart.”
This entry was posted in 3D Print Biotechnology and medicine posts., 3D Printing hobby products and design., 3D Printing Ideas, Patent. Fans of the day., 3D Printing industry news., 3D Printing information., 3D Printing Market share., Managing health with 3D printing., SV3DPrinter.com Policy. and tagged 3D printed a “rabbit-sized” heart, bioink, BIOLIFE4D, cardiomyocytes, extracellular matrix, Tel Aviv University.